Alcresta Therapeutics, Inc. is a biopharmaceutical company based in Newton Lower Falls, MA, specializing in the development of enzyme-based products for patients with rare diseases and fat malabsorption. Their innovative product, RELiZORB, is a digestive enzyme cartridge designed to assist individuals on enteral tube feeding who struggle with breaking down and absorbing fats due to conditions such as cystic fibrosis, short bowel syndrome, and pancreatitis.
With a mission to improve the nutritional outcomes and overall health of patients, Alcresta Therapeutics focuses on addressing the challenges faced by individuals who require enteral feeding for nutrition. Their patented microbead enzyme technology, iLipase, is incorporated into the RELiZORB cartridge, enabling the efficient breakdown of fat for easy ingestion and optimal absorption. Through their dedication to scientific research and clinical trials, Alcresta Therapeutics aims to provide effective solutions for patients living with serious medical conditions related to rare diseases.
Generated from the website